Back to top
more

DexCom (DXCM)

(Delayed Data from NSDQ)

$75.78 USD

75.78
9,237,060

-0.66 (-0.86%)

Updated Sep 18, 2025 04:00 PM ET

After-Market: $75.78 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (86 out of 245)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Universal Health (UHS) Q4 Earnings Beat on Solid Segments

by Zacks Equity Research

Universal Health's (UHS) fourth-quarter results indicate growing revenues in its segments resulting from higher patient volumes. Management expects adjusted EPS within $9.50-$10.50 for 2023.

Zacks Equity Research

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

by Zacks Equity Research

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

Zacks Equity Research

Community Health (CYH) Q4 Earnings Beat on Strong Admissions

by Zacks Equity Research

Community Health's (CYH) fourth-quarter results indicate growing patient volumes. However, management estimates net loss per share to lie between 65 cents and 5 cents in 2023.

Zacks Equity Research

DexCom (DXCM) Q4 Earnings Beat Estimates, Volumes Remain Strong

by Zacks Equity Research

DexCom's (DXCM) fourth-quarter results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.

Zacks Equity Research

DexCom (DXCM) Tops Q4 Earnings and Revenue Estimates

by Zacks Equity Research

DexCom (DXCM) delivered earnings and revenue surprises of 30.77% and 0.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

DexCom (DXCM) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

DexCom's (DXCM) fourth-quarter results are likely to reflect rising global awareness of its real-time CGM.

Zacks Equity Research

Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for XHE

Zacks Equity Research

DexCom (DXCM) Gains But Lags Market: What You Should Know

by Zacks Equity Research

DexCom (DXCM) closed the most recent trading day at $108.03, moving +0.3% from the previous trading session.

Zacks Equity Research

Should iShares Russell Mid-Cap Growth ETF (IWP) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for IWP

Zacks Equity Research

DexCom (DXCM) Gains But Lags Market: What You Should Know

by Zacks Equity Research

DexCom (DXCM) closed the most recent trading day at $106.72, moving +0.07% from the previous trading session.

Zacks Equity Research

Masimo's (MASI) Patient Monitoring Devices Favored by New Study

by Zacks Equity Research

Masimo's (MASI) patient monitoring devices continue to aid researchers in their assessment of different ventilatory strategies for brain oxygenation during thoracoscopic surgery.

Zacks Equity Research

DexCom (DXCM) Gains But Lags Market: What You Should Know

by Zacks Equity Research

DexCom (DXCM) closed the most recent trading day at $107.86, moving +1.56% from the previous trading session.

Zacks Equity Research

Should Vanguard MidCap Growth ETF (VOT) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for VOT

Zacks Equity Research

Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?

by Zacks Equity Research

Sector ETF report for XHE

Zacks Equity Research

DexCom (DXCM) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

DexCom (DXCM) closed at $107.14 in the latest trading session, marking a +0.92% move from the prior day.

Zacks Equity Research

DexCom (DXCM) Announces Solid Preliminary Q4 Revenues

by Zacks Equity Research

DexCom's (DXCM) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its CGM sales.

Zacks Equity Research

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio (Revised)

by Zacks Equity Research

Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

Zacks Equity Research

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

Zacks Equity Research

DexCom (DXCM) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, DexCom (DXCM) closed at $113.24, marking a +1.04% move from the previous day.

Zacks Equity Research

DexCom (DXCM) Stock Moves -0.1%: What You Should Know

by Zacks Equity Research

DexCom (DXCM) closed at $109.77 in the latest trading session, marking a -0.1% move from the prior day.

Zacks Equity Research

DexCom (DXCM) Stock Moves -0.94%: What You Should Know

by Zacks Equity Research

DexCom (DXCM) closed the most recent trading day at $113.68, moving -0.94% from the previous trading session.

Zacks Equity Research

DexCom (DXCM) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

In the latest trading session, DexCom (DXCM) closed at $114.63, marking a -1.39% move from the previous day.

Zacks Equity Research

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

Mark Vickery headshot

Top Research Reports for Walmart, Toyota Motor & Schlumberger

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), Toyota Motor Corporation (TM) and Schlumberger Limited (SLB).

Benjamin Rains headshot

3 Stocks to Buy for Long-Term Growth Upside

by Benjamin Rains

Investors might want to consider buying stocks after the strong first half of the fourth quarter. Today, we explore three stocks that are set to expand within three crucial growth industries.